Menu
Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 12
Fine needle aspiration cytology as a preliminary diagnostic tool in chondroid syringoma: a case report and review
Authors Syed MMA, Paudel U, Rajbhandari A, Pokhrel DB, Adhikari RC, Parajuli S
Received 24 November 2018
Accepted for publication 15 February 2019
Published 5 April 2019 Volume 2019:12 Pages 209—218
DOI https://doi.org/10.2147/CCID.S195733
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Jeffrey Weinberg
MM Aarif Syed,1 Upama Paudel,1 Aasiya Rajbhandari,2 Dinesh Binod Pokhrel,1 Ram Chandra Adhikari,2 Sudip Parajuli1
1Department of Dermatology and Venereology, Institute of Medicine, Tribhuvan University, Kathmandu, Nepal; 2Department of Pathology, Institute of Medicine, Tribhuvan University, Kathmandu, Nepal
Abstract: We report a case of chondroid syringoma (CS) in a 44-year-old male. He presented with a firm asymptomatic nodule in his left upper lip of 2-year duration. The initial clue to the diagnosis was made on fine needle aspiration cytology (FNAC), and a final diagnosis was based on histopathological examination. The case highlights the importance of FNAC in providing clues to the diagnosis of suspected cases of chondroid syringoma before performing large excisions and repair, which would require more skill and time. We have also reviewed the cytological findings of all the cases of benign CS reported until the current date.
Keywords: chondroid syringoma, pleomorphic adenoma, adnexal tumours, fine needle aspiration cytology
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.